The labelling index of marrow myeloblasts: a predictive test for relapse of acute non-lymphoblastic leukemia

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Leukemia & lymphoma·2016

Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy.

Leukemia & lymphoma·2016

Tandem inversion duplication within F8 Intron 1 associated with mild haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2015

Neonatal haemoglobinopathy screening in Belgium.

Journal of clinical pathology·2008

[Paradox: when a prothrombotic disorder is responsible for an upper gastrointestinal bleeding. Case report of hepatoportal sclerosis].

Revue medicale de Liege·2004

[Bilateral breast masses].

Revue medicale de Bruxelles·2000

HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.

Leukemia research·2026

Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis.

Leukemia research·2026

Comorbidity burden is a major independent prognostic factor in Waldenström Macroglobulinemia: A national cancer database retrospective study.

Leukemia research·2026

Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients.

Leukemia research·2026

Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia.

Leukemia research·2026

Inflammation-based scores and their dynamic changes as prognostic indicators in classical hodgkin lymphoma.

Leukemia research·2026

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Journal of visualized experiments : JoVE·2026

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Regenerative therapy·2026

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Regenerative therapy·2026

Beyond immune suppression: regenerative programs in regulatory T cells.

Cell insight·2026

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

BMJ neurology open·2026

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Antibody therapeutics·2026

Related Experiment Videos

The labelling index of marrow myeloblasts: a predictive test for relapse of acute non-lymphoblastic leukemia

Related Concept Videos

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy.

Tandem inversion duplication within F8 Intron 1 associated with mild haemophilia A.

Neonatal haemoglobinopathy screening in Belgium.

[Paradox: when a prothrombotic disorder is responsible for an upper gastrointestinal bleeding. Case report of hepatoportal sclerosis].

[Bilateral breast masses].

HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.

Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis.

Comorbidity burden is a major independent prognostic factor in Waldenström Macroglobulinemia: A national cancer database retrospective study.

Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients.

Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia.

Inflammation-based scores and their dynamic changes as prognostic indicators in classical hodgkin lymphoma.

Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

Beyond immune suppression: regenerative programs in regulatory T cells.

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

Related Experiment Videos

The labelling index of marrow myeloblasts: a predictive test for relapse of acute non-lymphoblastic leukemia

Related Concept Videos

Related Articles